Abstract
Importance: Monitoring health systems during and after natural disasters, epidemics, or outbreaks is critical for guiding policy decisions and interventions. When the effects of an event are long-lasting and difficult to detect in the short term, the accumulated effects can be devastating.
Objective: We aim to leverage the improved access to mortality data to develop data-driven approaches that can help monitor health systems and quantify the effects on mortality of natural disasters, epidemics, or outbreaks.
Design, Setting, and Participants: To demonstrate the utility of our approach we conducted several retrospective time-series analyses of mortality assessment after natural disasters. We obtained individual-level mortality records from the Department of Health of Puerto Rico from January 1985 to May 2020 to study the effects of hurricanes Hugo, Georges, and María in September 1989, September 1998, and September 2017, respectively. Further, we obtained daily mortality counts from Florida, New Jersey, and Louisiana’s Vital Statistic systems from January 2015 to December 2018, January 2007 to December 2015, and January 2003 to December 2006, respectively, to study the effects of hurricanes Irma in 2017, Sandy in 2013, and Katrina in 2005. Finally, we obtained individual-level mortality data from the Cook county, IL, medical examiners office, and state-specific weekly mortality counts from the Center for Disease Control and Prevention to assess the effect of the COVID-19 pandemic on the US health system.
Exposures: Hurricanes María, Georges, and Hugo in Puerto Rico, Irma in Florida, Sandy in New Jersey, and Katrina in Louisiana, the Chikungunya outbreak in Puerto Rico, and the COVID-19 pandemic in the United States.
Main Outcomes: We estimate and provide uncertainty assessments for percent increase from expected mortality, estimated excess deaths, and difference across groups.
Results: We found that the death rate increase in Puerto Rico after María and Georges was substantially higher than the other hurricanes we examined. Further, we find that excess mortality in the US was already above 100,000 on May 9, 2020, with over 58% of these occurred in New York, New Jersey, Massachusetts, and Pennsylvania, and that effects of this pandemic were worse for elderly black individuals compared to whites of the same age.
Conclusions and Relevance: Our approach can be used to monitor or assess health systems by estimating increased mortality rates and excess deaths from mortality records.
Key Points
Question: Can we estimate excess mortality and provide accurate uncertainty assessments from vital statistics data?
Findings: We developed statistical methodology that accounts for key sources of variability and provides accurate estimates and their standard errors for excess mortality. We applied the approach to datasets from several US states including periods affected by hurricanes and epidemics. We found an elevated and persistent increase in mortality after hurricanes in Puerto Rico that was substantially higher than in other US states. We also found that excess mortality in the US during the COVID-19 pandemic reached 100,000 by May 9, 2020. Finally, we found significant differences in the effects of this pandemic across racial groups in the US.
Meaning: Data-driven approaches can help monitor health systems and quantify the effects on mortality of natural disasters, epidemics, or outbreaks.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research reported in this publication was supported by the National Institutes of Health under award number R35GM131802
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Harvard Medical Campus Institutional Review Board
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We make our tools available through free and open source excessmort R package. All details of our analysis are available by examining the code which is made available on GitHub: https://github.com/rafalab/excess-mortality-paper The code for the R package implementing the methods is also available on GitHub: https://github.com/rafalab/excessmort.
